Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR 378.10
+0.20 (0.05%)
At close: Jan 22, 2026
NSE:INDRAMEDCO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 14,048 | 13,564 | 12,447 | 10,987 | 8,882 | 6,134 | Upgrade | |
Revenue Growth (YoY) | 6.51% | 8.97% | 13.29% | 23.70% | 44.80% | -26.17% | Upgrade |
Cost of Revenue | 5,568 | 5,278 | 5,040 | 4,630 | 4,059 | 3,257 | Upgrade |
Gross Profit | 8,480 | 8,286 | 7,407 | 6,357 | 4,823 | 2,877 | Upgrade |
Selling, General & Admin | 876.5 | 876.5 | 1,066 | 894.6 | 552.1 | 284.5 | Upgrade |
Other Operating Expenses | 5,019 | 4,961 | 4,396 | 3,947 | 3,070 | 2,182 | Upgrade |
Operating Expenses | 6,327 | 6,281 | 5,863 | 5,234 | 3,972 | 2,800 | Upgrade |
Operating Income | 2,153 | 2,005 | 1,545 | 1,123 | 851.3 | 76.6 | Upgrade |
Interest Expense | -29 | -30.3 | -10.6 | -4.6 | -6.1 | - | Upgrade |
Interest & Investment Income | 226.5 | 226.5 | 168.9 | 100.3 | 31.2 | 6.8 | Upgrade |
Other Non Operating Income (Expenses) | -1.4 | -32.4 | -30 | -38.2 | -28 | -33.4 | Upgrade |
EBT Excluding Unusual Items | 2,349 | 2,168 | 1,673 | 1,181 | 848.4 | 50 | Upgrade |
Gain (Loss) on Sale of Assets | -5.2 | -5.2 | -11.7 | -8.7 | -57.7 | -7.1 | Upgrade |
Pretax Income | 2,344 | 2,163 | 1,661 | 1,172 | 790.7 | 42.9 | Upgrade |
Income Tax Expense | 596.8 | 553.3 | 421.5 | 310.3 | 204.5 | 19.6 | Upgrade |
Net Income | 1,747 | 1,610 | 1,240 | 861.5 | 586.2 | 23.3 | Upgrade |
Net Income to Common | 1,747 | 1,610 | 1,240 | 861.5 | 586.2 | 23.3 | Upgrade |
Net Income Growth | 18.24% | 29.87% | 43.89% | 46.96% | 2415.88% | -94.66% | Upgrade |
Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade |
Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade |
EPS (Basic) | 19.06 | 17.56 | 13.52 | 9.40 | 6.39 | 0.25 | Upgrade |
EPS (Diluted) | 19.06 | 17.56 | 13.52 | 9.40 | 6.39 | 0.25 | Upgrade |
EPS Growth | 18.24% | 29.88% | 43.87% | 47.07% | 2456.00% | -94.75% | Upgrade |
Free Cash Flow | 1,430 | 1,204 | 1,308 | 998.9 | 648.2 | 58.5 | Upgrade |
Free Cash Flow Per Share | 15.60 | 13.14 | 14.26 | 10.90 | 7.07 | 0.64 | Upgrade |
Dividend Per Share | 4.500 | 4.500 | 4.500 | 3.000 | 2.500 | - | Upgrade |
Dividend Growth | - | - | 50.00% | 20.00% | - | - | Upgrade |
Gross Margin | 60.37% | 61.09% | 59.51% | 57.86% | 54.30% | 46.90% | Upgrade |
Operating Margin | 15.33% | 14.78% | 12.41% | 10.22% | 9.59% | 1.25% | Upgrade |
Profit Margin | 12.44% | 11.87% | 9.96% | 7.84% | 6.60% | 0.38% | Upgrade |
Free Cash Flow Margin | 10.18% | 8.88% | 10.51% | 9.09% | 7.30% | 0.95% | Upgrade |
EBITDA | 2,542 | 2,405 | 1,907 | 1,477 | 1,160 | 371 | Upgrade |
EBITDA Margin | 18.10% | 17.73% | 15.32% | 13.44% | 13.06% | 6.05% | Upgrade |
D&A For EBITDA | 389 | 400.7 | 362.8 | 354 | 308.3 | 294.4 | Upgrade |
EBIT | 2,153 | 2,005 | 1,545 | 1,123 | 851.3 | 76.6 | Upgrade |
EBIT Margin | 15.33% | 14.78% | 12.41% | 10.22% | 9.59% | 1.25% | Upgrade |
Effective Tax Rate | 25.46% | 25.58% | 25.37% | 26.48% | 25.86% | 45.69% | Upgrade |
Revenue as Reported | 14,305 | 13,790 | 12,616 | 11,087 | 8,913 | 6,141 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.